Where does Robert Tansley work?

Robert Tansley is Partner at Cambridge Innovation Capital.

What check size does Robert Tansley write?

Robert Tansley typically writes checks of $600K – $6M.

What boards does Robert Tansley sit on?

Robert Tansley holds tracked board seats at Inivata.

What companies has Robert Tansley invested in?

Investments tracked here include Abcodia, Carrick Therapeutics, Cmr Surgical, Gyroscopetx, Inivata, Morphogen-IX, PetMedix, Pretzel Therapeutics, Sortera.bio, Z Factor.

Where did Robert Tansley go to school?

Robert Tansley studied at University of Cambridge (M.Phil, Epidemiology & Biostatistics); London Business School (MBA); UCL (MBBS, Medicine).

Robert Tansley

Investor

Partner at Cambridge Innovation Capital

Cambridge, United Kingdom

Writes $600K – $6M checks · typically $3.3M

About

Robert Tansley is a trained surgeon-turned-investor who leverages clinical experience, backing major medtechs like CMR Surgical, serving as CMO and translating Cambridge academic research into scalable life sciences companies.

Contact· self-published, not guessed

r•••@cic.vcreveal

Invests in

AI & Machine LearningBiotechDeep TechHardwareHealthtechSemiconductors

Experience

MicrobioticaChief Medical Officercurrent2025 — presentCambridge, England, United Kingdom
MicrobioticaBoard Member2016 — 2025Cambridge, United Kingdom
Cambridge Innovation CapitalVenture Partnercurrent2025 — presentCambridge, England, United Kingdom
Cambridge Innovation CapitalPartner2014 — 2025Cambridge, United Kingdom
Pretzel TherapeuticsBoard Membercurrent2021 — presentBoston, MA
Sortera BioBoard Membercurrent2024 — presentCambridge, England, United Kingdom
Sortera BioExecutive Chairperson2024 — 2025Cambridge, England, United Kingdom
BioIndustry Association (BIA)Board Member2023 — 2025London Area, United Kingdom
T-Therapeutics LtdBoard Member2022 — 2025Greater Cambridge Area
ExvastatBoard Member2017 — 2025Cambridge, United Kingdom
PetMedix (acquired by Zoetis)Board Member2020 — 2023Cambridge, England, United Kingdom
ABCODIA LIMITED (acquired by GENinCODE plc)Board Member2015 — 2023
Carrick TherapeuticsBoard Observer2016 — 2022County Dublin, Ireland
CMR SurgicalBoard Member (2016-2019), Board Observer (2019-2021)2016 — 2021Cambridge, United Kingdom
Inivata (acquired by NeoGenomics)Board Member2014 — 2021Cambridge, United Kingdom and Research Park Triangle, NC
MORPHOGEN-IX LIMITED (acquired by Centessa Pharmaceuticals)Board Member2015 — 2021Cambridge, United Kingdom
STORM Therapeutics LimitedBoard Member2015 — 2018Cambridge, United Kingdom
Congenica (acquired by SeqOne)Board Member2015 — 2018Cambridge, United Kingdom
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV)Medical Director2011 — 2015Southampton, UK and Boston, MA
Tansley & TansleyDirector2009 — 2014Cambridge, United Kingdom
Treague LtdFounder, CEO2007 — 2009Cambridge, UK
Arakis Ltd (acquired by SOSEIMedical Director2004 — 2007Cambridge, UK
Hoffmann-La RocheClinical Team Leader2001 — 2004
MHRAMedical Assessor, Licensing Division1999 — 2001
SanofiMedical Advisor1996 — 1999
Clinical appointments at UCH, Westminster and Addenbrooke's Hospital CambridgeHospital Medicine1988 — 1996

Skills & more

Clinical Development36Pharmacovigilance5Regulatory Affairs10Clinical Trials12GCP4New Business Development2Diabetes7Clinical Research15Oncology7Medicine4Pharmacology4Drug Discovery5

+12 more

BiotechnologyFDADrug DevelopmentInfectious DiseasesR&DPharmaceuticsLifesciencesTherapeutic AreasPharmaceutical IndustryINDTranslational MedicineDermatology

From Robert's professional profile.

Deals · 1

InivataBoard seat

via Cambridge Innovation Capital · filed Jun 2020 · $60M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Investor

AbcodiaCarrick Therapeutics Cmr SurgicalGyroscopetxMorphogen-IXPetMedixPretzel TherapeuticsSortera.bioZ Factor

Sources: SEC Form D filings · the firm's website.

Colleagues at Cambridge Innovation Capital

Adam Glinsman

Investor at Cambridge Innovation Capital

Andrew Williamson

Managing Partner at Cambridge Innovation Capital

Andy Neely

Vice Chair at Cambridge Innovation Capital

Andy Richards

Investor at Cambridge Innovation Capital

Anne Horgan

Partner at Cambridge Innovation Capital

Christopher Tapper

Senior Associate at Cambridge Innovation Capital

Damian Crowther

Entrepreneur in Residence at Cambridge Innovation Capital

Dipesh Patel

Operating Partner at Cambridge Innovation Capital

Network1

Andrew Williamson

Managing Partner at Cambridge Innovation Capital

Investors connected to Robert in public investor directories — a warm-intro map.

Frequently asked questions

Who is Robert Tansley?: Robert Tansley is a trained surgeon-turned-investor who leverages clinical experience, backing major medtechs like CMR Surgical, serving as CMO and translating Cambridge academic research into scalable life sciences companies.
Where does Robert Tansley work?: Robert Tansley is Partner at Cambridge Innovation Capital.
What does Robert Tansley invest in?: Robert Tansley invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Semiconductors.
What check size does Robert Tansley write?: Robert Tansley typically writes checks of $600K – $6M.
What boards does Robert Tansley sit on?: Robert Tansley holds tracked board seats at Inivata.
What companies has Robert Tansley invested in?: Investments tracked here include Abcodia, Carrick Therapeutics, Cmr Surgical, Gyroscopetx, Inivata, Morphogen-IX, PetMedix, Pretzel Therapeutics, Sortera.bio, Z Factor.
Where did Robert Tansley go to school?: Robert Tansley studied at University of Cambridge (M.Phil, Epidemiology & Biostatistics); London Business School (MBA); UCL (MBBS, Medicine).

Same school

Also attended University of Cambridge893

Stewart ButterfieldCo-founder of Slack and Flickr Demis HassabisCo-founder & CEO of Google DeepMind Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General Catalyst Georgia StevensonInvestor at Index Ventures Hannah SealInvestor at Index Ventures Leah von SiemensPartner at Manta Ray Ventures

+ 887 more

Also attended London Business School541

Patrick ClaessenPartner at Cottonwood Technology Fund Dominic JacquessonInvestor at Index Ventures Sandra SchwarzerInvestor at Index Ventures Matt CherianVenture Partner at Monta Vista Capital Akshat GoenkaInvestor at Moonfire Ventures Giuseppe IademarcoHead of Global Partnership at P101 Ventures

+ 535 more

Also attended UCL396

Demis HassabisCo-founder & CEO of Google DeepMind André DuboisInvestor at Index Ventures Frédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire Ventures Marie FerriInvestor at Daphni Elena PantaziPartner & Head of Platform at Northzone

+ 390 more

Also attended Faculty of Pharmaceutical Medicine1

Mahesh KudariSenior Associate at SR One Capital Management

Shared employers

Also worked at Cambridge Innovation Capital17

Damian Crowtherex-AstraZeneca at PICUS CAPITAL William Tunstall-PedoeInvestor at Cambridge Innovation Capital Erik LangakerInvestor at Cambridge Innovation Capital Victoria WoodwardHead of Business Support at Cambridge Innovation Capital Tom PageHead of Investor Relations at Cambridge Innovation Capital Rob SprawsonPartner and CFO at Cambridge Innovation Capital

+ 11 more

About

Contact· self-published, not guessed

Invests in

Experience

Skills & more

Deals · 1

Other disclosed investments

Investor

Colleagues at Cambridge Innovation Capital

Network1

Frequently asked questions

Same school

Also attended University of Cambridge893

Also attended London Business School541

Also attended UCL396

Also attended Faculty of Pharmaceutical Medicine1

Shared employers

Also worked at Cambridge Innovation Capital17

Also worked at Sortera Bio1

Also worked at Carrick Therapeutics6

Also worked at STORM Therapeutics Limited6